Immunomodulation by Intravenous Immunoglobulin: Role of Regulatory T Cells

被引：60
作者：
Maddur, Mohan S. [1 ,2 ,3 ]
Othy, Shivashankar [1 ,2 ,3 ]
Hegde, Pushpa [1 ,2 ,3 ]
Vani, Janakiraman [1 ,2 ,3 ]
Lacroix-Desmazes, Sebastien [1 ,2 ,3 ]
Bayry, Jagadeesh [1 ,2 ,3 ]
Kaveri, Srini V. [1 ,2 ,3 ]
机构：
[1] Univ Paris 06, Ctr Rech Cordeliers, Equipe Immunopathol & Therapeut Immunointervent 1, UMR S 872, F-75006 Paris, France
[2] Univ Paris 05, UMR S 872, F-75006 Paris, France
[3] INSERM, Unite 872, F-75006 Paris, France
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2010年 / 30卷
关键词：
IVIG; intravenous immunoglobulin; regulatory T cells; autoimmune diseases; inflammation; immunomodulation; MONOCLONAL-ANTIBODY; MECHANISMS; THERAPY; CTLA-4; AUTOIMMUNITY; SUPPRESSION; TREGITOPES; TOLERANCE; DISEASES;
D O I：
10.1007/s10875-010-9394-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
An altered immune homeostasis as a result of deficiency or defective function of CD4(+)CD25(+)FoxP3(+) regulatory T cells (Tregs) is common in several autoimmune diseases. Hence, therapeutic strategies to render Tregs functionally competent are being investigated. Intravenous immunoglobulin (IVIG) is being increasingly used for the treatment of a wide range of autoimmune and inflammatory diseases. Recent studies have demonstrated that IVIG induces the expansion of Tregs and enhances their suppressive functions. These effects of IVIG on Tregs correlate with the beneficial effects of IVIG in patients with autoimmune diseases. Thus, modulation of Tregs by IVIG represents a novel mode of action that explains the therapeutic effects of IVIG in T cell-mediated autoimmune diseases. However, the molecular mechanisms involved in IVIG-mediated modulation of Tregs are unclear and need further investigation.
引用
收藏
页码：S4 / S8
页数：5
相关论文
共 24 条
[1]   Surveillance of Antigen-Presenting Cells by CD4+CD25+Regulatory T Cells in Autoimmunity Immunopathogenesis and Therapeutic Implications [J].
Andre, Sebastien ;
Tough, David F. ;
Lacroix-Desmazes, Sebastien ;
Kaveri, Srini V. ;
Bayry, Jagadeesh .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (05) :1575-1587
[2]   Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGF gene variants [J].
Barreto, Marta ;
Ferreira, Ricardo C. ;
Lourenco, Lara ;
Moraes-Fontes, Maria F. ;
Santos, Eugenia ;
Alves, Miguel ;
Carvalho, Claudia ;
Martins, Berta ;
Andreia, Rita ;
Viana, Joao F. ;
Vasconcelos, Carlos ;
Mota-Vieira, Luisa ;
Ferreira, Carlos ;
Demengeot, Jocelyne ;
Vicente, Astrid M. .
BMC IMMUNOLOGY, 2009, 10
[3]   Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy [J].
Bayry, Jagadeesh ;
Siberil, Sophie ;
Triebel, Frederic ;
Tough, David F. ;
Kaveri, Srin V. .
DRUG DISCOVERY TODAY, 2007, 12 (13-14) :548-552
[4]   Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action [J].
Bayry, Jagadeesh ;
Lacroix-Desmazes, Sebastien ;
Kazatchkine, Michel D. ;
Kaveri, Srini V. .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (05) :262-272
[5]   CTLA-4: a key protein in autoimmunity [J].
Bayry, Jagadeesh .
NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (05) :244-245
[6]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[7]   Tregitopes switch on Tregs [J].
Caspi, Rachel R. .
BLOOD, 2008, 112 (08) :3003-3004
[8]   Abnormality of circulating CD4+CD25+ regulatory T cell in patients with Guillain-Barre syndrome [J].
Chi, Lijun ;
Wang, Hua-Bing ;
Zhang, Ying ;
Wang, Wei-Zhi .
JOURNAL OF NEUROIMMUNOLOGY, 2007, 192 (1-2) :206-214
[9]   Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes" [J].
De Groot, Anne S. ;
Moise, Leonard ;
McMurry, Julie A. ;
Wambre, Erik ;
Van Overtvelt, Laurence ;
Moingeon, Philippe ;
Scott, David W. ;
Martin, William .
BLOOD, 2008, 112 (08) :3303-3311
[10]   Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin:: a critical factor in controlling experimental autoimmune encephalomyelitis [J].
Ephrem, Amal ;
Chamat, Souleima ;
Miquel, Catherine ;
Fisson, Sylvain ;
Mouthon, Luc ;
Caligiuri, Giuseppina ;
Delignat, Sandrine ;
Elluru, Sriramulu ;
Bayry, Jagadeesh ;
Lacroix-Desmazes, Sebastien ;
Cohen, Jose L. ;
Salomon, Benoit L. ;
Kazatchkine, Michel D. ;
Kaveri, Srini V. ;
Misra, Namita .
BLOOD, 2008, 111 (02) :715-722
123